Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9171321rdf:typepubmed:Citationlld:pubmed
pubmed-article:9171321lifeskim:mentionsumls-concept:C0042776lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C0030481lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C0147139lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C0076560lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C0178539lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C1336626lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C1442734lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C0279477lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C1704619lld:lifeskim
pubmed-article:9171321lifeskim:mentionsumls-concept:C1533179lld:lifeskim
pubmed-article:9171321pubmed:issue2lld:pubmed
pubmed-article:9171321pubmed:dateCreated1997-7-21lld:pubmed
pubmed-article:9171321pubmed:abstractTextThe reasons for the development of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in certain infected individuals remain poorly understood, but the susceptibility should involve both viral factors and host conditions. To assess simultaneously both virus-induced activation of infected cells and the cellular response to virus producing cells, an analysis of fractionated peripheral blood lymphocytes obtained from patients with HAM/TSP (n = 15) were compared with those of asymptomatic HTLV-I carriers (n = 9) in an age-matched manner. The in vitro propagation of HTLV-I infection was evaluated as the spontaneous thymidine incorporation into CD4+ cells, and proliferative response of CD8+ cells against cultured and irradiated autologous CD4+ cells was employed to analyze the HTLV-I-induced cellular response. The comparative analysis using these two parameters demonstrated that HAM/TSP patients were characterized by the concomitance of a high inducibility of HTLV-I propagation and a high cellular responsiveness against HTLV-I as compared with asymptomatic HTLV-I carriers, suggesting the involvement of both of these factors in disease susceptibility. In addition, the coupled evaluation of these two in vitro phenomena may offer a better diagnostic hallmark for HTLV-I seropositive myelopathy cases with other known cause of myelopathy.lld:pubmed
pubmed-article:9171321pubmed:languageenglld:pubmed
pubmed-article:9171321pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9171321pubmed:citationSubsetIMlld:pubmed
pubmed-article:9171321pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9171321pubmed:statusMEDLINElld:pubmed
pubmed-article:9171321pubmed:monthAuglld:pubmed
pubmed-article:9171321pubmed:issn0022-510Xlld:pubmed
pubmed-article:9171321pubmed:authorpubmed-author:NagaiMMlld:pubmed
pubmed-article:9171321pubmed:authorpubmed-author:OsameMMlld:pubmed
pubmed-article:9171321pubmed:authorpubmed-author:HallW WWWlld:pubmed
pubmed-article:9171321pubmed:authorpubmed-author:YamanaKKlld:pubmed
pubmed-article:9171321pubmed:authorpubmed-author:IjichiSSlld:pubmed
pubmed-article:9171321pubmed:authorpubmed-author:MachigashiraK...lld:pubmed
pubmed-article:9171321pubmed:issnTypePrintlld:pubmed
pubmed-article:9171321pubmed:volume149lld:pubmed
pubmed-article:9171321pubmed:ownerNLMlld:pubmed
pubmed-article:9171321pubmed:authorsCompleteYlld:pubmed
pubmed-article:9171321pubmed:pagination141-5lld:pubmed
pubmed-article:9171321pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:meshHeadingpubmed-meshheading:9171321-...lld:pubmed
pubmed-article:9171321pubmed:year1997lld:pubmed
pubmed-article:9171321pubmed:articleTitleIn vitro virus propagation and high cellular responsiveness to the infected cells in patients with HTLV-I-associated myelopathy (HAM/TSP).lld:pubmed
pubmed-article:9171321pubmed:affiliationThird Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Japan.lld:pubmed
pubmed-article:9171321pubmed:publicationTypeJournal Articlelld:pubmed